ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselCORETAG Holding AG
CORETAG Holding AG Logo
Verified· 2 sources

CORETAG Holding AG

Summary

About the company

CORETAG Holding AG is an oncology biotechnology company that develops radioligand-based diagnostic and therapeutic approaches for solid tumors. Its work centers on the Tumor Necrosis Targeting Platform® and the candidates CyanTag® and CyanCore® for diagnosis, therapy, and treatment monitoring.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered2
Tumor Necrosis Targeting Platform®
Development of targeted radioligands and radiopharmaceuticals based on a proprietary Tumor Necrosis Targeting Platform; includes diagnostics, therapy and treatment-response monitoring in solid tumors.
Radioligand therapy pipeline
Clinical and preclinical radioligand programs for difficult-to-treat solid tumors, including CyanTag®, CyanCore®, HQ-4® and further pipeline expansions with diagnostic and therapeutic isotopes.
Comparisons

CORETAG Holding AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CORETAG Holding AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CORETAG Holding AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 18
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-169.548.751
Founded
2019 · 7 years
Last commercial register change
December 5, 2024
Employees
1 to 10

Knowledge

No knowledge articles yet

Once CORETAG Holding AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

CD
CORETAG Diagnostics AG
Basel
CT
CORETAG Therapeutics AG
Basel
TP
Torpedo Pharmaceuticals AG
Basel
RI
Rocket Isotopes AG
Basel
RS
Regeneron Switzerland GmbH
Basel
TT
Tenpoint Therapeutics GmbH
Basel
3B
3T Biosciences Europe GmbH
Basel
RA
Rocketvax AG
Basel